Project Grant P01AI181934
Award Date
9/5/24
Completion Date
6/30/29
Dollars Obligated
$7.5M
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Boston, MA 02111, USA
Similar Awards
This $165,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports the development of an improved transposon mutagenesis system for comprehensive genetic analysis of Borrelia burgdorferi, the bacterium that causes Lyme disease. The project aims to create a high-efficiency transposon insertional mutagenesis system and employ transposon sequencing techniques to conduct...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $461,375 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Yale University. The grant, effective July 1, 2025 through June 30, 2027, will fund a project to systematically identify interactions between Lyme disease bacteria (Borrelia burgdorferi) and the extracellular, secreted, and transmembrane proteins of its tick vector, Ixodes scapularis. The project aims to develop a...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,663,244 project grant under CFDA 93.855, Allergy and Infectious Diseases Research, to President and Fellows of Harvard College (Harvard Medical School) on March 1, 2025. The project aims to characterize innate immune signaling pathways in the tick Ixodes scapularis, which is a vector for Lyme disease and other emerging infectious diseases. The research will combine cell culture-based methods with in vivo assays in...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $457,875.00 to the University of Connecticut Health Center to conduct research on the role of the alternative sigma factor RpoS in the persistence of Borrelia burgdorferi, the causative agent of Lyme disease, in mammalian hosts. The overarching objective is to elucidate how RpoS-dependent gene regulation...
The Virginia Commonwealth University was awarded a $746,009 Project Grant from the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. The grant falls under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support research examining the cyclic-di-GMP signaling pathway and its role in the enzootic cycle of Lyme disease from November 18, 2022 through October 31, 2027. Specifically, the grant will fund...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $191,250 to Washington State University (WSU) to conduct research on the immune evasion mechanism of the Lyme disease spirochete, Borrelia burgdorferi. The award supports mechanistic studies on the role of genetic factors in the antigenic variation of the VlsE surface protein, a key mechanism for persistent...
This Project Grant award of $509,130 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research at the University of South Florida to investigate the global virulence regulatory network of the Lyme disease pathogen Borrelia burgdorferi. The key objectives are to: 1) Define the BosR regulon and characterize how BosR-regulated genes contribute to the infectious cycle of B. burgdorferi; 2) Examine the biological roles of...
The Department of the Army Medical Command awarded $754,214 to The Research Foundation for the State University of New York at Stony Brook University under the Military Medical Research and Development program (CFDA 12.420) from September 1, 2022 to August 31, 2025. The project aims to develop peripheral blood biomarkers to diagnose active Lyme disease and post-treatment Lyme disease syndrome. Stony Brook University will investigate medical solutions for Lyme disease diagnosis through innovative...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $192,500.00 to the University of South Alabama to conduct research on the mechanisms of central nervous system invasion by the Lyme disease spirochete, Borrelia burgdorferi. The key objectives are to: (1) Determine the role of the blood-cerebrospinal fluid barrier as a site for B. burgdorferi and immune cell entry into the central nervous...
The National Science Foundation (NSF) awarded a $550,000 Project Grant under the NSF Technology, Innovation, and Partnerships (TIP) program to the University of California, Los Angeles (UCLA) to develop a rapid, multiplexed diagnostic tool for serological testing of tick-borne diseases (TBDs). This 2-year project seeks to improve blood-based detection of TBDs, including Lyme disease, Babesia, Anaplasma, and relapsing fever, through an innovative point-of-care (POC) serological assay. The goal is...